Updated September 24, 2026
Fujifilm Diosynth Biotechnologies U.S.A., Inc. agreed to a proposed settlement in Johnson et al. v. Fujifilm Diosynth Biotechnologies U.S.A., Inc., Case No. 26CV012339-910, pending in Wake County Superior Court in North Carolina. Fujifilm Diosynth is a contract development and manufacturing organization that helps pharmaceutical and biotechnology companies develop and produce medicines. The affected information related primarily to current and former employees. The case concerns a cybersecurity incident discovered in September 2025. The company reported that an unauthorized person acquired certain employee information around July 31, 2025. The potentially involved fields included names, Social Security numbers, dates of birth, driver's-license information, passport numbers, retirement account information, and medical information. The plaintiffs allege that Fujifilm Diosynth failed to protect private information. The company denies wrongdoing and liability, and the court has not decided that it violated any law. An approved claimant may choose either up to $2,500 for documented, unreimbursed incident-related losses or a $50 alternative cash payment without loss documentation. Either cash choice may be combined with two years of CyEx credit monitoring. The aggregate documented-loss benefit is capped at $175,000, so approved loss payments can be reduced proportionally. Claims, exclusions, and objections are due November 25, 2026. The final approval hearing is scheduled for December 11, 2026.
Requires reasonable records such as receipts, account records, telephone records, or emails. Self-prepared statements can explain other proof but cannot serve as the only documentation. Previously reimbursed expenses cannot be claimed again.
Available instead of the documented-loss payment. A valid claim is still required, and the administrator will determine whether the claimant is in the class.
Available in addition to either cash option. Enrollment instructions are scheduled after the court grants final approval and the settlement becomes effective.
A class member may select one cash option. The documented-loss option pays up to $2,500 for reasonable, supported, unreimbursed losses related to the incident and incurred from September 4, 2025 through November 25, 2026. The total available for this benefit is $175,000, so approved claims may be reduced pro rata. Instead, a class member may request a $50 alternative cash payment without documenting a loss. Both cash options may be combined with two years of CyEx Identify Defense Complete credit monitoring. Benefits are available only after final approval becomes effective.
Official settlement site: FLBDataSettlement.com. Class Action Pulse is not the settlement administrator or a law firm — always verify eligibility, deadlines, and payout details through the official source above.
Check your eligibility and get help understanding your claim. It's free and takes under a minute.
Fujifilm Diosynth develops and manufactures biologic medicines for pharmaceutical and biotechnology companies. The incident involved information the company held in its role as an employer, not a claim that every customer of a drug company was affected.
No. The plaintiffs make allegations about the company's data security. Fujifilm Diosynth denies the legal claims and wrongdoing. Preliminary approval authorizes notice and claims but does not decide liability.
No. The notice presents documented losses and the $50 payment as alternatives. Credit monitoring may be requested in addition to either cash choice.
No. A claimant must document an approved amount, and the total documented-loss benefit is capped at $175,000. Payments may be reduced proportionally if approved claims exceed that limit.
You receive no benefit. Unless you validly opt out by November 25, 2026, you will be bound by the settlement's release if it becomes final.
No. Class Action Pulse is not a law firm or settlement administrator and cannot guarantee eligibility, claim approval, or payment. Use the official materials.
